228
Views
3
CrossRef citations to date
0
Altmetric
Research Article

DNA Methylation at Diagnosis is Associated with Response to Disease-Modifying Drugs in Early Rheumatoid Arthritis

, , , , , , & show all
Pages 419-428 | Received 14 Apr 2016, Accepted 12 Oct 2016, Published online: 25 Nov 2016

References

  • Symmons D , TurnerG , WebbRet al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century . Rheumatology41 ( 7 ), 793 – 800 ( 2002 ).
  • Myasoedova E , CrowsonCS , KremersHM , TherneauTM , GabrielSE . Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007 . Arthritis Rheum.62 ( 6 ), 1576 – 1582 ( 2010 ).
  • O’Dell JR , HaireCE , EriksonNet al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications . N. Engl. J. Med.334 ( 20 ), 1287 – 1291 ( 1996 ).
  • O’Dell JR , LeffR , PaulsenGet al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial . Arthritis Rheum.46 ( 5 ), 1164 – 1170 ( 2002 ).
  • Nurmohamed MT , DijkmansBA . Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis . Drugs65 ( 5 ), 661 – 694 ( 2005 ).
  • Bottini N , FiresteinGS . Epigenetics in rheumatoid arthritis: a primer for rheumatologists . Curr. Rheumatol. Rep.15 ( 11 ), 372 ( 2013 ).
  • Glant TT , MikeczK , RauchTA . Epigenetics in the pathogenesis of rheumatoid arthritis . BMC Med.12 , 35 ( 2014 ).
  • Klein K , GayS . Epigenetic modifications in rheumatoid arthritis, a review . Curr. Opin. Pharmacol.13 ( 3 ), 420 – 425 ( 2013 ).
  • Kim YI , LoganJW , MasonJB , RoubenoffR . DNA hypomethylation in inflammatory arthritis: reversal with methotrexate . J. Lab. Clin. Med.128 ( 2 ), 165 – 172 ( 1996 ).
  • de Andres MC , Perez-PampinE , CalazaMet al. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate . Arthritis Res. Ther.17 , 233 ( 2015 ).
  • Esteller M , Garcia-FoncillasJ , AndionEet al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents . N. Engl. J. Med.343 ( 19 ), 1350 – 1354 ( 2000 ).
  • Plant D , WilsonAG , BartonA . Genetic and epigenetic predictors of responsiveness to treatment in RA . Nat. Rev. Rheumatol.10 ( 6 ), 329 – 337 ( 2014 ).
  • Cribbs A , FeldmannM , OppermannU . Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications . Ther. Adv. Musculoskelet. Dis.7 ( 5 ), 206 – 219 ( 2015 ).
  • Bird A . DNA methylation patterns and epigenetic memory . Genes Dev.16 ( 1 ), 6 – 21 ( 2002 ).
  • Glossop JR , EmesRD , NixonNBet al. Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations . Epigenetics9 ( 9 ), 1228 – 1237 ( 2014 ).
  • Glossop JR , EmesRD , NixonNBet al. Genome-wide profiling in treatment-naive early rheumatoid arthritis reveals DNA methylome changes in T- and B-lymphocytes . Epigenomics8 ( 2 ), 209 – 224 ( 2016 ).
  • Farragher TM , LuntM , FuB , BunnD , SymmonsDP . Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis . Ann. Rheum. Dis.69 ( 4 ), 689 – 695 ( 2010 ).
  • Romao VC , CanhaoH , FonsecaJE . Old drugs, old problems: where do we stand in the prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?BMC Med.11 , 17 ( 2013 ).
  • Smith SL , PlantD , EyreS , BartonA . The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis . Ann. Rheum. Dis.72 ( 7 ), 1118 – 1124 ( 2013 ).
  • Grabiec AM , ReedquistKA . The ascent of acetylation in the epigenetics of rheumatoid arthritis . Nat. Rev. Rheumatol.9 ( 5 ), 311 – 318 ( 2013 ).
  • Cope AP . T cells in rheumatoid arthritis . Arthritis Res. Ther.10 ( Suppl. 1 ), S1 ( 2008 ).
  • Peres RS , LiewFY , TalbotJet al. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis . Proc. Natl Acad. Sci. USA112 ( 8 ), 2509 – 2514 ( 2015 ).
  • Carvalheiro H , DuarteC , Silva-CardosoS , da SilvaJA , Souto-CarneiroMM . CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity . Arthritis Rheumatol.67 ( 2 ), 363 – 371 ( 2015 ).
  • Kuuliala K , KuulialaA , KoivuniemiRet al. Constitutive STAT3 phosphorylation in circulating CD4+ T lymphocytes associates with disease activity and treatment response in recent-onset rheumatoid arthritis . PLoS ONE10 ( 9 ), e0137385 ( 2015 ).
  • Aletaha D , NeogiT , SilmanAJet al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative . Ann. Rheum. Dis.69 ( 9 ), 1580 – 1588 ( 2010 ).
  • Prevoo ML , van’t HofMA , KuperHH , van LeeuwenMA , van de PutteLB , van RielPL . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis . Arthritis Rheum.38 ( 1 ), 44 – 48 ( 1995 ).
  • van Gestel AM , PrevooML , van’t HofMA , van RijswijkMH , van de PutteLB , van RielPL . Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria . Arthritis Rheum.39 ( 1 ), 34 – 40 ( 1996 ).
  • van Gestel AM , HaagsmaCJ , van RielPL . Validation of rheumatoid arthritis improvement criteria that include simplified joint counts . Arthritis Rheum.41 ( 10 ), 1845 – 1850 ( 1998 ).
  • Bibikova M , BarnesB , TsanCet al. High density DNA methylation array with single CpG resolution . Genomics98 ( 4 ), 288 – 295 ( 2011 ).
  • Glossop JR , NixonNB , EmesRDet al. Epigenome-wide profiling identifies significant differences in DNA methylation between matched-pairs of T- and B-lymphocytes from healthy individuals . Epigenetics8 ( 11 ), 1188 – 1197 ( 2013 ).
  • Mill J , YazdanpanahS , GuckelE , ZieglerS , KaminskyZ , PetronisA . Whole genome amplification of sodium bisulfite-treated DNA allows the accurate estimate of methylated cytosine density in limited DNA resources . Biotechniques41 ( 5 ), 603 – 607 ( 2006 ).
  • Don RH , CoxPT , WainwrightBJ , BakerK , MattickJS . ‘Touchdown’ PCR to circumvent spurious priming during gene amplification . Nucleic Acids Res.19 ( 14 ), 4008 ( 1991 ).
  • Haworth KE , FarrellWE , EmesRDet al. Combined influence of gene-specific cord blood methylation and maternal smoking habit on birth weight . Epigenomics5 ( 1 ), 37 – 49 ( 2013 ).
  • Aryee MJ , JaffeAE , Corrada-BravoHet al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays . Bioinformatics30 ( 10 ), 1363 – 1369 ( 2014 ).
  • Maksimovic J , GordonL , OshlackA . SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips . Genome Biol.13 ( 6 ), R44 ( 2012 ).
  • Du P , ZhangX , HuangCCet al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis . BMC Bioinformatics11 , 587 ( 2010 ).
  • Finckh A , LiangMH , van HerckenrodeCM , de PabloP . Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis . Arthritis Rheum.55 ( 6 ), 864 – 872 ( 2006 ).
  • de Vries-Bouwstra JK , Goekoop-RuitermanYP , VerpoortKNet al. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies . Arthritis Rheum.58 ( 5 ), 1293 – 1298 ( 2008 ).
  • Klareskog L , CatrinaAI , PagetS . Rheumatoid arthritis . Lancet373 ( 9664 ), 659 – 672 ( 2009 ).
  • Scirè CA , VerstappenSM , MirjafariHet al. Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk Arthritis Register . Arthritis Care Res. (Hoboken)63 ( 7 ), 945 – 952 ( 2011 ).
  • Plant D , WebsterA , NairNet al. Differential methylation as a biomarker of response to etanercept in patients with rheumatoid arthritis . Arthritis Rheumatol.68 ( 6 ), 1353 – 1360 ( 2016 ).
  • Hider SL , SilmanAJ , ThomsonW , LuntM , BunnD , SymmonsDP . Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?Ann. Rheum. Dis.68 ( 1 ), 57 – 62 ( 2009 ).
  • Wessels JA , van der KooijSM , le CessieSet al. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis . Arthritis Rheum.56 ( 6 ), 1765 – 1775 ( 2007 ).
  • Saevarsdottir S , WallinH , SeddighzadehMet al. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial . Ann. Rheum. Dis.70 ( 3 ), 469 – 475 ( 2011 ).
  • Ma MH , IbrahimF , WalkerDet al. Remission in early rheumatoid arthritis: predicting treatment response . J. Rheumatol.39 ( 3 ), 470 – 475 ( 2012 ).
  • Le Goff C , Morice-PicardF , DagoneauNet al. ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-β bioavailability regulation . Nat. Genet.40 ( 9 ), 1119 – 1123 ( 2008 ).
  • Schmidt-Weber CB , BlaserK . Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation . Curr. Opin. Immunol.16 ( 6 ), 709 – 716 ( 2004 ).
  • Li MO , FlavellRA . TGF-β: a master of all T cell trades . Cell134 ( 3 ), 392 – 404 ( 2008 ).
  • Pohlers D , BeyerA , KoczanD , WilhelmT , ThiesenHJ , KinneRW . Constitutive upregulation of the transforming growth factor-β pathway in rheumatoid arthritis synovial fibroblasts . Arthritis Res. Ther.9 ( 3 ), R59 ( 2007 ).
  • Afrache H , GouretP , AinoucheS , PontarottiP , OliveD . The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response . Immunogenetics64 ( 11 ), 781 – 794 ( 2012 ).
  • Abeler-Dorner L , SwamyM , WilliamsG , HaydayAC , BasA . Butyrophilins: an emerging family of immune regulators . Trends Immunol.33 ( 1 ), 34 – 41 ( 2012 ).
  • Svensson B , SchaufelbergerC , TelemanA , TheanderJ . Remission and response to early treatment of RA assessed by the disease activity score . Rheumatology (Oxford)39 ( 9 ), 1031 – 1036 ( 2009 ).
  • Ellis JA , MunroJE , ChavezRAet al. Genome-scale case-control analysis of CD4+ T-cell DNA methylation in juvenile idiopathic arthritis reveals potential targets involved in disease . Clin. Epigenetics4 ( 1 ), 20 ( 2012 ).
  • Cribbs AP , KennedyA , PennHet al. Methotrexate restores regulatory T cell function through demethylation of the foxp3 upstream enhancer in patients with rheumatoid arthritis . Arthritis Rheumatol.67 ( 5 ), 1182 – 1192 ( 2015 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.